FDA-Drug2026-07-29Class IICHEMICAL
Ascend Laboratories amlodipine-olmesartan tablets recalled for substandard active ingredient
UNDECLARED INGREDIENTSNationwide distribution
Ascend amlodipine-olmesartan tablets recalled for low drug content
Ascend Laboratories is recalling one lot of amlodipine and olmesartan medoxomil combination tablets (10 mg/20 mg) because the olmesartan medoxomil active ingredient is below the required amount. This means affected tablets may not work as intended to lower blood pressure.
- Check if your amlodipine-olmesartan tablets are from lot 25121311 (expiration 3/31/2028).
- Contact your pharmacy or doctor if you have this lot — do not stop taking your blood pressure medication without medical guidance.
- Your pharmacist or doctor can provide a replacement or alternative medication.
Hazard
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Sold states
Nationwide in the USA
Affected count
6,192 bottles
Manufactured in
135 Us Highway 202 206 Ste 15, N/A, Bedminster, NJ, United States
Products
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0712-2026More Ascend Laboratories, LLC recalls
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief